BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/15/2025 9:03:19 AM | Browse: 106 | Download: 387
 |
Received |
|
2025-05-22 14:33 |
 |
Peer-Review Started |
|
2025-05-26 00:13 |
 |
First Decision by Editorial Office Director |
|
2025-06-07 02:07 |
 |
Return for Revision |
|
2025-06-07 02:07 |
 |
Revised |
|
2025-07-02 13:03 |
 |
Publication Fee Transferred |
|
2025-07-06 13:41 |
 |
Second Decision by Editor |
|
2025-08-11 02:13 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2025-08-25 11:15 |
 |
Articles in Press |
|
2025-08-25 11:15 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2025-10-09 15:45 |
 |
Publish the Manuscript Online |
|
2025-10-15 09:03 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Basic Study |
| Article Title |
Nicotinamide mononucleotide protects against diabetic nephropathy via IL-6/Rab5-mediated crosstalk between proximal tubular epithelial cells and podocytes
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Dong-Qing Zha, Ping Gao and Xiao-Yan Wu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Hubei Provincial Natural Science Foundation |
2023AFB732 |
| Scientific Research Project of Hubei Provincial Health Commission |
WJ2023M053 |
|
| Corresponding Author |
Xiao-Yan Wu, MD, Division of Nephrology, Zhongnan Hospital of Wuhan University, 169 Donghu Road, Wuhan 430070, Hubei Province, China. wuxiaoyan2k6@whu.edu.cn |
| Key Words |
Diabetic nephropathy; Podocyte injury; Interleukin-6; Rab5 signaling; Nicotinamide mononucleotide; Proximal tubular epithelial cell |
| Core Tip |
This study identified a novel mechanism in diabetic nephropathy (DN), in which high glucose-induced interleukin-6 (IL-6) secretion by proximal tubular epithelial cells activated Rab5 signaling in podocytes, followed by nephrin endocytosis and structural damage. Importantly, nicotinamide mononucleotide (NMN) effectively interrupted this pathogenic IL-6/Rab5-mediated intercellular crosstalk, thereby preserving podocyte integrity, reducing glomerular injury, and decreasing albuminuria. These findings highlight NMN as a potential therapeutic strategy for mitigation of DN by targeting IL-6/Rab5 signaling. |
| Publish Date |
2025-10-15 09:03 |
| Citation |
Zha DQ, Gao P, Wu XY. Nicotinamide mononucleotide protects against diabetic nephropathy via IL-6/Rab5-mediated crosstalk between proximal tubular epithelial cells and podocytes. World J Diabetes 2025; 16(10): 109782 |
| URL |
https://www.wjgnet.com/1948-9358/full/v16/i10/109782.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v16.i10.109782 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.